Uganda HIV/TB COHRE Training Program

乌干达艾滋病毒/结核病 COHRE 培训计划

基本信息

  • 批准号:
    7386694
  • 负责人:
  • 金额:
    $ 14.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-06-28 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Although the seroprevalence of HIV has declined in Uganda over the past 10 years, the HIV epidemic in Uganda is far from controlled. In the face of the HIV epidemic, tuberculosis rates are high and associated with significant mortality. With the advent of antiretroviral therapy, prevention strategies alone are no longer sufficient to meet the current needs in Uganda. There is now a moral imperative to bring the remarkable advances in the field of HIV to developing countries like Uganda. One key step in the rebuilding of the Ugandan public health infrastructure resulted from a unique collaboration between the Ugandan Ministry of Health, the Ministry of Defense and Makerere University to form the Joint Clinical Research Center (JCRC). The JCRC is a research and health care facility devoted entirely to HIV and leads the way in opening Africa to antiretroviral therapy. Through the years, the JCRC has formed strong collaborations with Case Western Reserve University (CWRU), the National Tuberculosis and Leprosy Control Programme (NTLP), Makerere and Mbarara Universities. The proposed training program will build on these strong relationships with the common mission of controlling HIV and TB. The goals of this training program are to expand the national capacity to address the public health and scientific challenges of the evolving HIV and TB epidemic in Uganda through clinical, operational and health services research. Through this training program Uganda will build the capacity to translate basic and clinical research findings into public health policy and interventions, and to evaluate their effectiveness. The training program will build on a growing number of clinical research projects on HIV and TB, but will extend the findings of these studies to the public health and policy arena. The goals will be met through a coherent program of degree and non-degree training in collaboration with CWRU, that will strengthen the capacity in Uganda to conduct integrated clinical, operational and health services research related to HIV and TB. The research training in this program will be linked to the ongoing research and program activities at the JCRC in Kampala, Uganda, CWRU, in the US, Mbarara University of Sciences and Technology, NTLP, Kampala City Council, CDC, USAID and Elizabeth Glaser Pediatric Foundation.
描述(申请人提供):尽管乌干达的艾滋病毒血清阳性率在过去10年中有所下降,但乌干达的艾滋病毒流行远未得到控制。在艾滋病毒流行的情况下,结核病发病率很高,而且死亡率很高。随着抗逆转录病毒疗法的出现,单靠预防战略已不足以满足乌干达目前的需要。现在有一种道德上的当务之急,把艾滋病毒领域的显着进步带给像乌干达这样的发展中国家。重建乌干达公共卫生基础设施的一个关键步骤是乌干达卫生部、国防部和Makerere大学之间独特的合作,成立了联合临床研究中心(JCRC)。JCRC是一个完全致力于艾滋病毒的研究和保健机构,在向非洲开放抗逆转录病毒治疗方面走在了前列。多年来,JCRC与凯斯西储大学(CWRU)、国家结核病和麻风病控制方案(NTLP)、Makerere大学和Mbarara大学建立了强有力的合作关系。拟议的培训计划将建立在与控制艾滋病毒和结核病的共同使命的这些牢固关系的基础上。这一培训计划的目标是通过临床、业务和卫生服务研究,扩大国家能力,以应对乌干达不断发展的艾滋病毒和结核病疫情带来的公共卫生和科学挑战。通过这一培训方案,乌干达将建设将基础和临床研究成果转化为公共卫生政策和干预措施并评估其有效性的能力。该培训计划将建立在越来越多的艾滋病毒和结核病临床研究项目的基础上,但将把这些研究的结果扩展到公共卫生和政策领域。这些目标将通过与CWRU合作的学位和非学位培训的连贯计划来实现,该计划将加强乌干达开展与艾滋病毒和结核病有关的综合临床、业务和卫生服务研究的能力。该项目的研究培训将与设在乌干达坎帕拉的JCRC、美国CWRU、姆巴拉拉科技大学、NTLP、坎帕拉市议会、疾控中心、美国国际开发署和伊丽莎白·格拉泽儿科基金会正在进行的研究和项目活动联系起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher C. Whalen其他文献

Linkage and association analysis of candidate genes for TB and TNFα cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes
  • DOI:
    10.1007/s00439-007-0357-8
  • 发表时间:
    2007-04-13
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Catherine M. Stein;Sarah Zalwango;Allan B. Chiunda;Christopher Millard;Dmitry V. Leontiev;Amanda L. Horvath;Kevin C. Cartier;Keith Chervenak;W. Henry Boom;Robert C. Elston;Roy D. Mugerwa;Christopher C. Whalen;Sudha K. Iyengar
  • 通讯作者:
    Sudha K. Iyengar
Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
短期抗结核治疗期间人类免疫缺陷病毒 1 型相关肺结核的临床过程。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Schwander;S. Schwander;M. Dietrich;PETER N. Mugyenyi;C. Kityo;A. Okwera;John L. Johnson;P. Nsubuga;S. Ruesch;Christopher C. Whalen
  • 通讯作者:
    Christopher C. Whalen
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
感染艾滋病毒的乌干达人结核菌素和念珠菌皮试反应性不稳定。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    24.7
  • 作者:
    John L. Johnson;S. Nyole;A. Okwera;Christopher C. Whalen;P. Nsubuga;Vukosava Pekovic;Robin Huebner;Robert S. Wallis;PETER N. Mugyenyi;R. Mugerwa;J. Ellner
  • 通讯作者:
    J. Ellner
Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
人类免疫缺陷病毒感染成人硫醋酮治疗肺结核期间药物不良反应的危险因素。

Christopher C. Whalen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher C. Whalen', 18)}}的其他基金

Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program
研究结核病的数字移动技术:一个多学科项目
  • 批准号:
    10676557
  • 财政年份:
    2023
  • 资助金额:
    $ 14.02万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10493262
  • 财政年份:
    2021
  • 资助金额:
    $ 14.02万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10665020
  • 财政年份:
    2021
  • 资助金额:
    $ 14.02万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10271646
  • 财政年份:
    2021
  • 资助金额:
    $ 14.02万
  • 项目类别:
Computational and Molecular Epidemiology Training in TB and HIV in Uganda
乌干达结核病和艾滋病毒计算和分子流行病学培训
  • 批准号:
    9301687
  • 财政年份:
    2015
  • 资助金额:
    $ 14.02万
  • 项目类别:
Computational and Molecular Epidemiology Training in TB and HIV in Uganda
乌干达结核病和艾滋病毒计算和分子流行病学培训
  • 批准号:
    9097840
  • 财政年份:
    2015
  • 资助金额:
    $ 14.02万
  • 项目类别:
Community Transmission of Tuberculosis Urban Africa
非洲城市结核病的社区传播
  • 批准号:
    9761955
  • 财政年份:
    2012
  • 资助金额:
    $ 14.02万
  • 项目类别:
Community Transmission of Tuberculosis Urban Africa
非洲城市结核病的社区传播
  • 批准号:
    10226961
  • 财政年份:
    2012
  • 资助金额:
    $ 14.02万
  • 项目类别:
Uganda HIV/TB COHRE Training Program
乌干达艾滋病毒/结核病 COHRE 培训计划
  • 批准号:
    7806570
  • 财政年份:
    2004
  • 资助金额:
    $ 14.02万
  • 项目类别:
Uganda HIV/TB COHRE Training Program
乌干达艾滋病毒/结核病 COHRE 培训计划
  • 批准号:
    6763819
  • 财政年份:
    2004
  • 资助金额:
    $ 14.02万
  • 项目类别:

相似海外基金

Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
  • 批准号:
    10106976
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
  • 批准号:
    ES/Y00860X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
  • 批准号:
    EP/Y024516/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
  • 批准号:
    24K00390
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
  • 批准号:
    10076185
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Collaborative R&D
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
  • 批准号:
    MR/Y003837/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
  • 批准号:
    MR/Y019695/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Research Grant
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
  • 批准号:
    MR/X022943/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Fellowship
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
  • 批准号:
    MR/Y00955X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
  • 批准号:
    MR/Y015614/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了